Correlation Between Pharvaris and ProMIS Neurosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and ProMIS Neurosciences, you can compare the effects of market volatilities on Pharvaris and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and ProMIS Neurosciences.

Diversification Opportunities for Pharvaris and ProMIS Neurosciences

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pharvaris and ProMIS is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Pharvaris i.e., Pharvaris and ProMIS Neurosciences go up and down completely randomly.

Pair Corralation between Pharvaris and ProMIS Neurosciences

Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.82 times more return on investment than ProMIS Neurosciences. However, Pharvaris BV is 1.22 times less risky than ProMIS Neurosciences. It trades about -0.05 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.08 per unit of risk. If you would invest  2,335  in Pharvaris BV on August 29, 2024 and sell it today you would lose (194.00) from holding Pharvaris BV or give up 8.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Pharvaris BV  vs.  ProMIS Neurosciences

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
ProMIS Neurosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProMIS Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pharvaris and ProMIS Neurosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and ProMIS Neurosciences

The main advantage of trading using opposite Pharvaris and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.
The idea behind Pharvaris BV and ProMIS Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges